Raghavendra Vasudeva

2.9k total citations · 1 hit paper
19 papers, 2.4k citations indexed

About

Raghavendra Vasudeva is a scholar working on Psychiatry and Mental health, Pathology and Forensic Medicine and Physiology. According to data from OpenAlex, Raghavendra Vasudeva has authored 19 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Psychiatry and Mental health, 6 papers in Pathology and Forensic Medicine and 6 papers in Physiology. Recurrent topics in Raghavendra Vasudeva's work include Migraine and Headache Studies (9 papers), Trigeminal Neuralgia and Treatments (6 papers) and Pain Mechanisms and Treatments (4 papers). Raghavendra Vasudeva is often cited by papers focused on Migraine and Headache Studies (9 papers), Trigeminal Neuralgia and Treatments (6 papers) and Pain Mechanisms and Treatments (4 papers). Raghavendra Vasudeva collaborates with scholars based in United States, India and Canada. Raghavendra Vasudeva's co-authors include Joyce A. DeLeo, Flobert Tanga, Maria D. Rutkowski, Javed N. Agrewala, Vinod Singh, John H. Krege, Suzanne Klise, Rashna Khanna, David Kudrow and Michael Case and has published in prestigious journals such as Journal of Neuroscience, SHILAP Revista de lepidopterología and Neurology.

In The Last Decade

Raghavendra Vasudeva

18 papers receiving 2.4k citations

Hit Papers

Inhibition of Microglial Activation Attenuates the Develo... 2003 2026 2010 2018 2003 200 400 600

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Raghavendra Vasudeva United States 12 1.7k 1.1k 468 391 357 19 2.4k
Sarah M. Sweitzer United States 25 1.9k 1.1× 1.1k 1.0× 274 0.6× 464 1.2× 374 1.0× 60 2.5k
Koichi Obata Japan 32 2.8k 1.6× 1.8k 1.7× 358 0.8× 853 2.2× 373 1.0× 48 4.2k
Raymond W. Colburn United States 23 1.9k 1.1× 1.3k 1.2× 268 0.6× 456 1.2× 305 0.9× 40 2.9k
Wioletta Makuch Poland 37 2.2k 1.3× 1.4k 1.3× 366 0.8× 666 1.7× 509 1.4× 71 3.2k
Ewelina Rojewska Poland 34 2.0k 1.2× 1.1k 1.0× 374 0.8× 481 1.2× 516 1.4× 57 2.8k
Maria D. Rutkowski United States 17 1.7k 1.0× 920 0.9× 301 0.6× 260 0.7× 318 0.9× 20 2.1k
Norimitsu Morioka Japan 31 1.0k 0.6× 916 0.9× 376 0.8× 827 2.1× 160 0.4× 107 2.3k
Xiao‐Ying Hua United States 30 1.7k 1.0× 1.9k 1.7× 172 0.4× 1.3k 3.3× 289 0.8× 45 3.1k
Xu‐Hong Wei China 24 1.2k 0.7× 657 0.6× 252 0.5× 342 0.9× 205 0.6× 42 1.7k
Xiao‐Jun Xu Sweden 37 2.3k 1.3× 2.0k 1.9× 140 0.3× 1.1k 2.8× 299 0.8× 105 3.5k

Countries citing papers authored by Raghavendra Vasudeva

Since Specialization
Citations

This map shows the geographic impact of Raghavendra Vasudeva's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Raghavendra Vasudeva with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Raghavendra Vasudeva more than expected).

Fields of papers citing papers by Raghavendra Vasudeva

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Raghavendra Vasudeva. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Raghavendra Vasudeva. The network helps show where Raghavendra Vasudeva may publish in the future.

Co-authorship network of co-authors of Raghavendra Vasudeva

This figure shows the co-authorship network connecting the top 25 collaborators of Raghavendra Vasudeva. A scholar is included among the top collaborators of Raghavendra Vasudeva based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Raghavendra Vasudeva. Raghavendra Vasudeva is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Vincent, Maurice, Mário Fernando Prieto Peres, Raghavendra Vasudeva, et al.. (2021). Lasmiditan Efficacy in Mild Versus Moderate or Severe Migraine Headaches (1811). Neurology. 96(15_supplement). 1 indexed citations
3.
Lipton, Richard B., Simin Baygani, Stewart J. Tepper, et al.. (2021). A close association of freedom from pain, migraine-related functional disability, and other outcomes: results of a post hoc analysis of randomized lasmiditan studies SAMURAI and SPARTAN. The Journal of Headache and Pain. 22(1). 101–101. 2 indexed citations
4.
Peres, Mário Fernando Prieto, Raghavendra Vasudeva, Simin Baygani, et al.. (2021). Lasmiditan efficacy in migraine attacks with mild vs. moderate or severe pain. Current Medical Research and Opinion. 37(6). 1031–1038. 5 indexed citations
5.
Brandes, Jan Lewis, Suzanne Klise, John H. Krege, et al.. (2020). Long-term safety and efficacy of lasmiditan for acute treatment of migraine: Final results of the GLADIATOR study. SHILAP Revista de lepidopterología. 3. 11 indexed citations
6.
Tepper, Stewart J., Raghavendra Vasudeva, John H. Krege, et al.. (2020). Evaluation of 2‐Hour Post‐Dose Efficacy of Lasmiditan for the Acute Treatment of Difficult‐to‐Treat Migraine Attacks. Headache The Journal of Head and Face Pain. 60(8). 1601–1615. 20 indexed citations
7.
Brandes, Jan Lewis, David Kudrow, Suzanne Klise, et al.. (2019). Long-term Safety and Efficacy of Lasmiditan for Acute Treatment of Migraine Over a One-Year Period: Interim Results of an Open-Label Phase 3 Study (GLADIATOR) (P1.10-021). Neurology. 92(15_supplement). 2 indexed citations
8.
Ashina, Messoud, Raghavendra Vasudeva, Louise Lombard, et al.. (2019). Onset of Efficacy Following Oral Treatment with Lasmiditan for the Acute Treatment of Migraine (S17.007). Neurology. 92(15_supplement). 1 indexed citations
9.
Ashina, Messoud, Raghavendra Vasudeva, Louise Lombard, et al.. (2019). Onset of Efficacy Following Oral Treatment With Lasmiditan for the Acute Treatment of Migraine: Integrated Results From 2 Randomized Double‐Blind Placebo‐Controlled Phase 3 Clinical Studies. Headache The Journal of Head and Face Pain. 59(10). 1788–1801. 30 indexed citations
10.
Brandes, Jan Lewis, Suzanne Klise, John H. Krege, et al.. (2019). Interim results of a prospective, randomized, open-label, Phase 3 study of the long-term safety and efficacy of lasmiditan for acute treatment of migraine (the GLADIATOR study). Cephalalgia. 39(11). 1343–1357. 66 indexed citations
11.
Vasudeva, Raghavendra, Flobert Tanga, & Joyce A. DeLeo. (2004). Complete Freunds adjuvant‐induced peripheral inflammation evokes glial activation and proinflammatory cytokine expression in the CNS. European Journal of Neuroscience. 20(2). 467–473. 494 indexed citations
12.
Vasudeva, Raghavendra, Flobert Tanga, Maria D. Rutkowski, & Joyce A. DeLeo. (2003). Anti-hyperalgesic and morphine-sparing actions of propentofylline following peripheral nerve injury in rats: mechanistic implications of spinal glia and proinflammatory cytokines. Pain. 104(3). 655–664. 180 indexed citations
13.
Vasudeva, Raghavendra, Flobert Tanga, & Joyce A. DeLeo. (2003). Attenuation of Morphine Tolerance, Withdrawal-Induced Hyperalgesia, and Associated Spinal Inflammatory Immune Responses by Propentofylline in Rats. Neuropsychopharmacology. 29(2). 327–334. 227 indexed citations
14.
Vasudeva, Raghavendra, Flobert Tanga, & Joyce A. DeLeo. (2003). Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy. Journal of Pharmacology and Experimental Therapeutics. 306(2). 624–630. 687 indexed citations breakdown →
15.
Vasudeva, Raghavendra, Maria D. Rutkowski, & Joyce A. DeLeo. (2002). The Role of Spinal Neuroimmune Activation in Morphine Tolerance/Hyperalgesia in Neuropathic and Sham-Operated Rats. Journal of Neuroscience. 22(22). 9980–9989. 369 indexed citations
16.
Vasudeva, Raghavendra, et al.. (2001). Possible antioxidant mechanism in melatonin reversal of aging and chronic ethanol-induced amnesia in plus-maze and passive avoidance memory tasks. Free Radical Biology and Medicine. 30(6). 595–602. 120 indexed citations
17.
Vasudeva, Raghavendra, et al.. (2001). Melatonin enhances Th2 cell mediated immune responses: Lack of sensitivity to reversal by naltrexone or benzodiazepine receptor antagonists. Molecular and Cellular Biochemistry. 221(1-2). 57–62. 63 indexed citations
18.
Vasudeva, Raghavendra, et al.. (2000). Possible mechanisms of action in melatonin reversal of morphine tolerance and dependence in mice. European Journal of Pharmacology. 409(3). 279–289. 45 indexed citations
19.
Vasudeva, Raghavendra, et al.. (2000). Melatonin reversal of lipopolysacharides-induced thermal and behavioral hyperalgesia in mice. European Journal of Pharmacology. 395(1). 15–21. 84 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026